Markus Maeurer

Has grant

University of Mainz

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

FCImuno - Valorization and Technology Transfer Center in Immunotherapy of the Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud

Open Date: 2019-01-01

Close Date: 2020-12-01

Grant: Close

Production of transgenic T cells

Open Date: 2001-01-01

Close Date: 2004-01-01

Grant: Close

Mechanistic and immunological studies on the role of HPV16 and HPV18 E6/7 mutations in cervical cancer and its precursors

Open Date: 1996-01-01

Close Date: 2005-12-01

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Mathieu Chevalier

Assistant Professor

FRANCE

View details

Chakaya Jeremiah Muhwa

Professor, Global Respiratory Health

Liverpool School of Tropical Medicine

UNITED KINGDOM

View details

laurence ZITVOGEL

Université Paris-Saclay

FRANCE

View details

Matthew Bates

Associate Professor

University of Lincoln

UNITED KINGDOM

View details

Lisa Derosa

Assistant Professor

Université Paris-Saclay

FRANCE

View details

Safae TERRISSE

INSERM

FRANCE

View details

Eleni Aklillu

Karolinska Institutet

SWEDEN

View details

Angelo Raggioli

Head

ITALY

View details

Stefania Capone

head of preclinical and clinical immunology

AKERN Srl

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Markus Maeurer

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies.

The Qatar FIFA World Cup 2022 and camel pageant championships increase risk of MERS-CoV transmission and global spread.

SARS-CoV-2 Specific Immune Response and Inflammatory Profile in Advanced HIV-Infected Persons during a COVID-19 Outbreak.

Vaccination for monkeypox prevention in persons with high-risk sexual behaviours to control on-going outbreak of monkeypox virus clade 3.

Blue Skies research is essential for ending the Tuberculosis pandemic and advancing a personalized medicine approach for holistic management of Respiratory Tract infections.

The WHO Global Tuberculosis 2021 Report – not so good news and turning the tide back to End TB

World TB Day 2022: Revamping and Reshaping Global TB Control Programs by Advancing Lessons learnt from the COVID-19 pandemic.

The polarity and specificity of antiviral T lymphocyte responses determine susceptibility to SARS-CoV-2 infection in cancer patients and healthy individuals.

Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts

GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults

Collaborators (9)

Mathieu Chevalier

Chakaya Jeremiah Muhwa

laurence ZITVOGEL

Matthew Bates

Lisa Derosa

Safae TERRISSE

Eleni Aklillu

Angelo Raggioli

Stefania Capone

Make your next move.